EFFECT OF DEXAMETHASONE ON INTERFERON-α-INDUCED DIFFERENTIATION OF MONOCYTES TO DENDRITIC CELLS

• Published in: Medit͡s︡inskai͡a︡ immunologii͡a Vol. 18; no. 4; p. 347
• Main Authors: Kurochkina, Yu D, O Yu Leplina, Tikhonova, M A, Tyrinova, T V, Batorov, E V, Sizikov, A E, Ostanin, A A, Chernykh, E R
• Format: Journal Article
• Language: Russian
• Published: Saint Petersburg Russian Association of Allerologists and Clinical Immuniologists, St. Petersburg Branch 01.01.2016
• Subjects: Autoimmune diseases; CD14 antigen; CD83 antigen; CD86 antigen; Cell culture; Chemokines; Dendritic cells; Dexamethasone; Glucocorticoids; Granulocyte-macrophage colony-stimulating factor; Histocompatibility antigen HLA; Immunomodulation; Inflammation; Interferon; Interleukin 1; Interleukin 12; Interleukin 2; Interleukin 6; Lymphocytes T; Monocytes; RANTES; Studies; TLR2 protein; Toll-like receptors
• ISSN: 1563-0625; 2313-741X
• DOI: 10.15789/1563-0625-2016-4-347-356

Type I Interferons are potent inducers of monocyte’s differentiation into dendritic cells (DCs). However, sensitivity of these DCs to tolerogenic effect of glucocorticoids has not been previously investigated. The aim of this study was to investigate the effect of dexamethasone upon maturation and functions of interferonalpha-induced DCs (IFN-DC) derived from healthy donors. DCs were generated from blood monocytes cultured for 5 days with GM-CSF and IFNα, in absence or with addition of dexamethasone (10-6 M), applied on the 3rd day. Addition of dexamethasone inhibited IFN-DC maturation, which manifested with increasing numbers of CD14+ cells and decreased percentage of CD83+ DCs. Dexamethasone did not significantly influence HLA-DR, CD86 and B7H1 expression. However, it caused a 2-fold increase of tolerogenic TLR-2 molecule expression. Along with suppression of IFN-DC maturation, dexamethasone inhibited production of proinflammatory/Th1 cytokines (TNFα, IL-1, IL-2, IFNγ, IL-12), and some chemokines (MIP-1α, RANTES). Dexamethasone-treated IFN-DCs exhibited a 2-fold lower allostimulatory activity in mixed lymphocyte culture (MLC). Worth of note, the capacity of IFN-DCs to stimulate T cell proliferative response in allo-MLC showed direct correlation with CD83 expression on DCs, and an inverse correlation with CD14 and TLR-2. Evaluation of Th1/Th2-polarizing activity of IFN-DCs showed that dexamethasone exerted a pronounced inhibitory effect upon ability of DCs to stimulate T cells for IFNγ production, along with lowgrade suppressive effect upon ability of DCs to induce IL-6 production, thus being indicative for a dominance of Th2-polarizing activity of IFN-DCs under the influence of dexamethasone. In general, the data obtained show that IFN-DCs are sensitive to tolerogenic action of dexamethasone, and, hence, the IFN-DCs may mediate the immunomodulatory effect of glucocorticosteroids and represent novel candidate cells for the development of therapeutic tolerogenic DC-based vaccines applicable for management of autoimmune disorders.